Life Sciences Tools & Services
股价
$138.44
-0.93%市值
$39.23B
今日最高
$140.88
今日最低
$138.02
A (Agilent Technologies) delivered strong Q2 FY2026 results with revenue of $1.84B (+10.0% YoY), operating income surging 33.0% to $399M, and net income jumping 57.7% to $339M, reflecting meaningful margin expansion and earnings leverage.
关键风险:Operating Cash Flow Decline Despite Earnings Growth
Year-to-date operating cash flow fell 16.4% to $545M even as net income rose sharply, indicating a potential disconnect between reported earnings and cash generation. This could reflect working capital build-up or unfavorable timing of receivables and payables. Sustained divergence between earnings and cash flow warrants monitoring.
同属 Life Sciences Tools & Services 行业的其他公司